Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.8 USD | -1.95% | -18.39% | -52.11% |
Mar. 22 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
Mar. 21 | Cabaletta Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.11% | 531M | |
-2.50% | 103B | |
+1.92% | 95.28B | |
+1.46% | 22.15B | |
-15.79% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.68% | 16.05B | |
+5.28% | 13.68B | |
+35.08% | 12.17B |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- HC Wainwright Adjusts Price Target on Cabaletta Bio to $25 From $17, Keeps Buy Rating